Clinical Trial Update: OIT and Xolair® (Omalizumab) in Cow's Milk Allergy [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating oral immunotherapy (OIT) with Xolair (omalizumab) for milk allergy has completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Milk Allergy

Drugs mentioned

• Xolair (omalizumab)

Snippet

Sponsor: Hugh A Sampson, MD | Conditions: Milk Allergy | Phase 2 | Status: COMPLETED | Results posted: 2016-04-06